Effectiveness and acceptability of ventilation modifications in healthcare facilities, Liberia 2022–2023
Antimicrobial Stewardship & Healthcare Epidemiology · 2025 · 5 (1)
DOI: 10.1017/ash.2025.10077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 22.08.2025. Verfasst von Ronan F Arthur und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Stanford University, Palo Alto, CA, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the effectiveness and acceptability of ventilation interventions in naturally ventilated hospitals in Liberia.
Design
Difference-in-differences analysis of pre- and post-air changes per hour of intervention and control spaces.
Setting
Hospitals in Bong and Montserrado Counties, Liberia.
Participants
Seventy patient care spaces were evaluated at baseline. Six spaces underwent physical intervention modifications, while 2 spaces were assessed for indirect effects and 2 others used as controls. Healthcare workers were interviewed to assess ventilation knowledge and acceptability.
Interventions
Ventilation interventions included the installation of window screens, louvered doors and windows, and wind turbines.
Methods
We measured carbon dioxide levels with portable meters and documented persons per room to estimate per-person ventilation rates in both L/s/person for the initial assessment and air changes per hour (ACH) in the intervention. Measurements were taken in patient care spaces in 7 hospitals in Liberia. Healthcare worker acceptability was evaluated via structured interviews.
Results
Two-thirds (46/70) of patient care spaces were below the WHO-recommended ventilation threshold of 60 L/s/person. Six spaces underwent ventilation interventions, including placement of window screens (3), wind turbines (2), and louvered doors and windows (1), with 2 additional spaces being indirectly affected by these interventions and 2 more spaces serving as controls. Ventilation improved by an average of 2 ACH in the spaces with wind turbines and louvered doors and windows. Overall acceptability of the interventions was high.
Conclusions
Implementing interventions to improve ventilation in naturally ventilated healthcare facilities is efficacious, feasible, and acceptable, though longer-term evaluations should assess sustainability.
Autor:innen und Institutionen
- School of Medicine, Stanford University, Palo Alto, CA, USA.
- Department of Infectious Diseases, Infection Control, and Employee Health, MD Anderson Cancer Center, Houston, TX, USA.
- Partnership for Research on Vaccines and Infectious Diseases in Liberia, Liberia.
- National Public Health Institute of Liberia, Monrovia, Liberia.
- Stanford Photonics Research Center, Stanford University, Palo Alto, CA, USA.
ORCID-Profile: Ronan F Arthur, Ashley Styczynski
Zitieren
APA
Arthur, R. F., Styczynski, A., Srinivasan, K., Tandanpolie, A., Bemah, P., Bell, E., Andrews, J. R., Baer, T., & Salinas, J. L. (2025). Effectiveness and acceptability of ventilation modifications in healthcare facilities, Liberia 2022–2023. Antimicrobial Stewardship & Healthcare Epidemiology, 5(1). https://doi.org/10.1017/ash.2025.10077
Vancouver
Arthur RF, Styczynski A, Srinivasan K, Tandanpolie A, Bemah P, Bell E, et al. Effectiveness and acceptability of ventilation modifications in healthcare facilities, Liberia 2022–2023. Antimicrobial Stewardship & Healthcare Epidemiology. 2025;5(1). doi:10.1017/ash.2025.10077
BibTeX
@article{Arthur2025,
author = {Arthur, Ronan F and Styczynski, Ashley and Srinivasan, Krithika and Tandanpolie, Amos and Bemah, Philip and Bell, Ethan and Andrews, Jason R and Baer, Tom and Salinas, Jorge L},
title = {Effectiveness and acceptability of ventilation modifications in healthcare facilities, Liberia 2022–2023},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2025},
volume = {5},
number = {1},
doi = {10.1017/ash.2025.10077}
}
EUVIMED